About-us technologies products Clinical-trials collaborations news careers contact-us
About Philogen

Philogen is a Swiss-Italian integrated biotechnology company founded in 1996, with the mission to develop innovative biopharmaceuticals for the treatment of angiogenesis-related disorders.....>>

About Philochem

Philochem is a fully owned daughter company of Philogen and represents the Discovery Unit of the Philogen group.

Philochem is based in Otelfingen (Zurich, Switzerland).>>

Recent News

Wien (Austria),
November 6th, 2014

Prof. Dario Neri is awarded
the Phoenix Preis 2014 for Pharmaceutical Sciences.
The award recognizes the contribution of our immunocytokine Teleukin
as a new pharmaceutical
to treat Acute Myeloid Leukemia.

Upcoming Events

January 27th, 2015

Dario Neri will present "Immunocytokines for the Therapy of Cancer and of Chronic Inflammation" at Biochemical Pharmacology Discussion Group
(NY Academy Sciences/Boehringer).